VOLITIONRX LTD Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Volitionrx Ltd quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2011 to Q2 2024.
  • Volitionrx Ltd Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$7.06M, a 26.1% increase year-over-year.
  • Volitionrx Ltd Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$32.8M, a 2.35% increase year-over-year.
  • Volitionrx Ltd annual Net Income (Loss) Attributable to Parent for 2023 was -$35.7M, a 16.6% decline from 2022.
  • Volitionrx Ltd annual Net Income (Loss) Attributable to Parent for 2022 was -$30.6M, a 13.4% decline from 2021.
  • Volitionrx Ltd annual Net Income (Loss) Attributable to Parent for 2021 was -$27M, a 32.3% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$32.8M -$7.06M +$2.49M +26.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$35.3M -$8.47M +$401K +4.52% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-14
Q4 2023 -$35.7M -$8.8M -$1.46M -19.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-25
Q3 2023 -$34.2M -$8.45M -$641K -8.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$33.6M -$9.55M -$1.82M -23.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$31.8M -$8.87M -$1.15M -15% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-14
Q4 2022 -$30.6M -$7.34M +$772K +9.52% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-25
Q3 2022 -$31.4M -$7.81M -$631K -8.78% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$30.7M -$7.73M -$2.16M -38.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-14
Q1 2022 -$28.6M -$7.72M -$1.59M -26% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-14
Q4 2021 -$27M -$8.11M -$2.95M -57.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 -$24M -$7.18M -$2.85M -65.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$21.2M -$5.57M -$531K -10.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$20.7M -$6.13M -$266K -4.54% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 -$20.4M -$5.16M -$1.6M -45.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 -$18.8M -$4.34M -$155K -3.71% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$18.6M -$5.04M -$886K -21.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 -$17.8M -$5.86M -$1.66M -39.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 -$16.1M -$3.56M +$730K +17% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-22
Q3 2019 -$16.8M -$4.18M +$296K +6.61% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$17.1M -$4.16M +$435K +9.47% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-12
Q1 2019 -$17.6M -$4.2M +$449K +9.64% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-12
Q4 2018 -$18M -$4.29M -$225K -5.53% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-20
Q3 2018 -$17.8M -$4.48M -$584K -15% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$17.2M -$4.59M -$1.13M -32.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 -$16.1M -$4.65M -$1.3M -38.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-08-12
Q4 2017 -$14.8M -$4.06M -$1.08M -36.1% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-13
Q3 2017 -$13.7M -$3.89M -$414K -11.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 -$13.3M -$3.46M -$514K -17.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 -$12.8M -$3.35M -$858K -34.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$11.9M -$2.98M -$297K -11.1% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-01
Q3 2016 -$11.6M -$3.48M -$517K -17.4% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$11.1M -$2.95M -$1.08M -57.7% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 -$10M -$2.49M -$482K -24% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 -$9.53M -$2.69M -$1.74M -185% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-10
Q3 2015 -$7.79M -$2.96M +$2.93M +49.7% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$10.7M -$1.87M -$2.69M -329% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$8.03M -$2.01M +$184K +8.4% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 -$8.21M -$942K -$113K -13.6% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-11
Q3 2014 -$8.1M -$5.89M -$4.97M -537% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 -$3.13M $817K +$1.86M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-11
Q1 2014 -$5M -$2.19M -$1.29M -142% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
Q4 2013 -$3.71M -$829K Oct 1, 2013 Dec 31, 2013 10-K 2015-03-18
Q3 2013 -$926K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 -$1.05M -$116K -12.5% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-01
Q1 2013 -$908K -$106K -13.2% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q2 2012 -$931K -$291K -45.5% Apr 1, 2012 Jun 30, 2012 10-Q 2012-08-14
Q1 2012 -$802K -$467K -139% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-06
Q2 2011 -$640K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 -$335K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.